Experimental neonatal syphilis in a susceptible (C4D) and a resistant (Albany) strain of guinea pig.
Despite similar levels of natural antibodies and treponemicidal activity, 83% of fourth complement component-deficient (C4D) mother guinea pigs developed ulcerative lesions to a challenge of 5 x 10(7) Treponema pallidum, whereas 75% of offspring 1 to 5 days old were temporarily (2-3 months) resistant to development of dermal lesions. In contrast, only 17% of Albany-strain mothers developed small papular lesions, while 68% of 1- to 5-day-old newborns developed large papular or ulcerative lesions within 9-15 days postinfection. These findings, together with the late development of both dermal lesions and antibodies in C4D neonates, preclude the concept of an antibody-associated natural resistance. T. pallidum infection in either C4D or Albany neonates was not associated with depletion of any particular cell population in lymphoid tissue. However, marked age- and strain-dependent histologic differences were noted. Histologic examination of lymph nodes and spleens from 17-day-old and 3- to 4-month-old animals showed that maturation of lymphoid tissues in C4D animals lagged behind the Albany strain at either age. Moreover, 75% of C4D newborns contained significantly higher levels of immunomodulatory alpha 1 fetoprotein than Albany neonates. The possibility that differences in susceptibility to T. pallidum infection between C4D and Albany guinea pigs as neonates and again as adults is the result of genetically associated changes in immunologic recognition is discussed.
Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany 12201-0509.
V
V
Wicher
K
K
Wicher
U
U
Rudofsky
J
J
Zabek
A
A
Jakubowski
S
S
Nakeeb
D000818:Animals; D000831:Animals, Newborn; D000907:Antibodies, Bacterial / Q000032:analysis; D000917:Antibody Formation; D003181:Complement C4 / Q000172:deficiency*; D015935:Complement C4b; D005260:Female; D006168:Guinea Pigs; D007116:Immunization, Passive; D008297:Male; D008431:Maternal-Fetal Exchange; D009500:Neutralization Tests; D010446:Peptide Fragments / Q000172:deficiency*; D011247:Pregnancy; D012867:Skin / Q000473:pathology; D013590:Syphilis, Congenital / Q000276:immunology*; D014210:Treponema pallidum / Q000276:immunology; D000509:alpha-Fetoproteins / Q000032:analysis
D000907:Antibodies, Bacterial; D003181:Complement C4; D010446:Peptide Fragments; D000509:alpha-Fetoproteins; D015935:Complement C4b; C032261:complement C4d